USA: Mount Sinai PACS clinic and Dr David Putrino

As for this particular bit of "BioBS", while I have certainly picked up on a fair degree of animus toward Putrino on this board, I did not realize that the possibility of different approaches being required for different subgroups of pwME was understood to be unworthy of consideration. May I ask why? Happy to make another thread if this isn't the place for it.
Oh I agree with you. I was commenting on him taking up lactate theories as if proven. Not the subgroup division. I agree with him on that point.
 
Oh I agree with you. I was commenting on him taking up lactate theories as if proven. Not the subgroup division. I agree with him on that point.
Ah - understood. And yes, this sort of vociferous assertion that it's all been figured out, no need to actually finish or even run any studies, is clearly endemic. I have to assume that the refusal or inability to display any uncertainty is trained into researchers and clinicians. This is certainly the case in my corner of academia, but I was in the humanities, which doesn't excuse it, but does mean that the consequences tend to be a little less life-and-death.
 
Last edited:
I have to assume that this refusal or inability to display any uncertainty is trained into people. This is certainly the case in my corner of academia
I had similar experience in studying Social Data Science. A field you’d think would have to be very careful because its very complex and the data is often biased. But the profs basically treated the data as inherently true and objective.

Academia really needs a big epistemic humility injection.
 
Not sure what this refers to?
Mounjaro ( and other weight loss jabs) are creating a lot of news over here. From 1st Sept, it's quoted that prices of some doses of the mounjaro jab will triple so that many people will be unable to afford them.
see https://www.s4me.info/threads/a-thread-for-those-concerned-about-weight-gain.25/post-635571

i noticed that Cort has published an article that goes wider than this about wider benefits of the GLP1 drugs.

The big issue here is how much of the demand will be met by the NHS. It seems that it will be very little. Only those with a BMI of over 40/45 ( I have seen both quoted ) plus 4 specified health conditions will be eligible leaving I think it's about 1 1/2 million ( exact fig not checked) to continue to fund it privately which not all will be able to afford to do. Lots of concern expressed.

Edit: Since writing this the Times has reported ( see above link) that Eli Lilly has further reduced its supply of mounjaro into UK before 1st Sept creating even more shortages.
 
Last edited:
Back
Top Bottom